Drugs

Sunshine Heart Announces 3Q12 Financial Results

EDEN PRAIRIE, MN and SYDNEY, AUSTRALIA: Key Regulatory and Financing Milestones Achieved ...

Medivation Announces Participation at Upcoming Investor Conferences

SAN FRANCISCO, CA: ...

Flamel Technologies Announces Third Quarter 2012 Results and Other Updates

LYON, FRANCE: Conference Call With Management to Take Place at 8:30 AM EST on November 5, 2012 ...

Cornerstone Therapeutics to Host Third Quarter 2012 Conference Call

CARY, NC: ...

Flamel Technologies Announces Projected Release Date of Third Quarter 2012 Results and Conference Call

LYON, FRANCE: ...

Sarepta Therapeutics Announces Third Quarter 2012 Financial Results and Corporate Update Conference Call

CAMBRIDGE, MA: ...

NuPathe Announces Closing of $28 Million Private Placement and Changes to Its Board of Directors

CONSHOHOCKEN, PA: ...

Sunshine Heart's Feasibility Study Data to Be Presented at 2012 Transcatheter Cardiovascular Therapeutics Conference

EDEN PRAIRIE, MN and SYDNEY, AUSTRALIA: Twelve-Month Follow-Up Data for Patients Enrolled in the C-Pulse Heart Assist System Clinical Feasibility Study to Be Presented ...

Flamel Technologies Announces FDA Acceptance of New Drug Application

LYON, FRANCE: ...

HTG Molecular Diagnostics Introduces the EDGE System at AMP Conference

TUCSON, AZ: ...